Ohlbe
★★★

France,
2020-04-28 23:01
(310 d 13:10 ago)

Posting: # 21358
Views: 2,509
 

 FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe
Activity
 Admin contact
21,366 posts in 4,462 threads, 1,493 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Friday 11:11 CET (Europe/Vienna)

The statistician has no magic touch by which
he may come in at the stage of tabulation
and make something of nothing.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5